Celularity Total Current Liabilities from 2010 to 2025
| CELU Stock | USD 2.05 0.08 3.76% |
Total Current Liabilities | First Reported 2019-03-31 | Previous Quarter 53.7 M | Current Value 69.2 M | Quarterly Volatility 29.1 M |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 3.4 M or Total Revenue of 56.9 M, as well as many indicators such as Price To Sales Ratio of 0.8, Dividend Yield of 0.0 or PTB Ratio of 5.41. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Total Current Liabilities | Build AI portfolio with Celularity Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.